Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
141 hedge funds and large institutions have $630M invested in Surmodics in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 2 closing their positions.
1,250% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
49% more capital invested
Capital invested by funds: $424M → $630M (+$206M)
41% more call options, than puts
Call options by funds: $4.06M | Put options by funds: $2.87M
23% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 40
22% more funds holding
Funds holding: 116 → 141 (+25)
1.65% more ownership
Funds ownership: 84.48% → 86.12% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$11.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$4.04M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.31M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.68M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.5M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$10.6M |
| 3 |
Millennium Management
New York
|
-$3.89M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$3.83M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
-$1.56M |
SRDX Hedge Fund Activity: Q2 2018 in Review
141 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2018, worth a combined $630M — up 49% from $424M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SRDX positions and 2 closed out — a net gain of 25 holders — while 49 added to existing stakes and 40 trimmed.
The largest buyer was BlackRock, adding an estimated $11.6M. The largest seller was Wellington Management Group, cutting an estimated $12.5M.
- 141 institutional investors held Surmodics (SRDX) as of Q2 2018, up from 116 in Q1 2018.
- Funds reported $630M of Surmodics stock for Q2 2018, up 49% quarter-over-quarter.
- 27 funds opened new Surmodics positions in Q2 2018 and 2 closed out, a net change of +25 holders.
- The largest Surmodics buyer in Q2 2018 was BlackRock, an estimated $11.6M added.
- The largest Surmodics seller in Q2 2018 was Wellington Management Group, an estimated $12.5M sold.
Based on aggregated 13F filings for Q2 2018.